This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Surg. 2000;135:1114.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Rocco et al¹ found that patients treated with fluconazole had a longer length of stay in the intensive care unit and hospital and a higher mortality. This study has several shortcomings, limiting the conclusions being made. The patient groups are not comparable. The authors should have used the Acute Physiology and Chronic Health Evaluation III expected mortality instead of the score when they compared groups for outcome, as underlying disease can make an important difference on mortality. Furthermore, the fluconazole-treated patients are more debilitated and sick, suggested by the higher use of steroids and antibiotics and the higher number of yeast infection sites. In general, fungal infections occur in patients with a strongly debilitated physical condition who are already hospitalized for a longer period.² Fungal infections might have an attributable mortality.³ Hence, we are convinced that the excess length of stay as well as the worse prognosis of these patients . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?